Koutif Therapeutics koutiftherapeutics.com


Koutif Therapeutics is developing an inhibitor of E3 ligase Fbxo3, which is implicated in the pathogenesis of inflammatory conditions such as neuropathic pain, bronchiolitis obliterans syndrome, irritable bowel disease, chronic obstructive pulmonary disease, rheumatoid arthritis, and acute lung injury.

Koutif Therapeutics is developing an inhibitor of E3 ligase Fbxo3, which is implicated in the pathogenesis of inflammatory conditions such as neuropathic pain, bronchiolitis obliterans syndrome, irritable bowel disease, chronic obstructive pulmonary ...Show all

Company (Alive / Active)

Phone: 216-455-3216

Fax:

20600 Chagrin Boulvard
Suite 21
Beachwood, 44122
Ohio, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Koutif Therapeutics $2.6M Oct 4, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Koutif Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)